Response Biomedical (V.RBM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Response Biomedical (V.RBM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rob who wrote (357)	11/28/2000 6:14:03 PM
From: Rob	Read Replies (1) of 655

No Material Change.... Response Biomedical Corp RBM Shares issued 27,353,148 Nov 27 close $0.35 Tue 28 Nov 2000 News Release Mr. Bruce Colwill reports There has been no material change in the company's affairs to explain the recent activity in the market for its common shares. Response Biomedical is continuing key progress in the commercialization of the RAMP system, a proprietary platform technology capable of supporting a broad menu of quantitative tests. Product development is on track such that the company is on schedule for commercial launch of the first RAMP tests for cardiac markers in the United States and European markets in 2001. In business development, the company is in discussions with several interested parties in the United States and Europe for marketing and distribution of RAMP cardiac marker tests. The progress made throughout this year, including successful completion of feasibility on a dixogin assay and the third party correlation study reported in June, has put the company in a position to expand these business development efforts. WARNING: The company relies upon litigation protection for "forward-looking" statements. (c) Copyright 2000 Canjex Publishing Ltd. stockwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next